Mechanism of electrochemical capture of CO2 via redox cycle of chlorinated 1,4-naphthoquinone in BMIMBF4: An in-situ FT-IR spectroelectrochemical approach

Add time:08/28/2019    Source:sciencedirect.com

The mechanisms of electrochemical capture of CO2 via redox cycle of 1,4-naphthoquinone (1,4-NQ), 2,3-dichloro-1,4-naphthoquinone (DCNQ) and 2-chloro-1,4-naphthoquinone (CNQ) in 1-butyl-3-methylimidazolium tetrafluoroborate (BMIMBF4) have been investigated by cyclic voltammetry (CV) and in-situ FT-IR spectroelectrochemistry techniques. In the absence of CO2, 1,4-NQ and DCNQ undergo a reversible two-step one-electron process while CNQ not. In addition, their two successive electron transfer processes in ionic liquid (IL) are different from that of molecular solvent. There is only a small difference in peak potential between two-step reduction, which possibly due to the ion-pair effects. Meanwhile, the reduction potentials of DCNQ and CNQ shift positively due to the electron-withdrawing effects of chlorine groups. The radical anion (Q−) and dianion (Q2−) formed during the electrochemical reduction can be used as nucleophiles to attack the eletrophilic carbon center of CO2 and form a stable CO2 adduct. For 1,4-NQ, 2 equiv. of CO2 can be captured during the electrochemical reduction of 1,4-NQ. Whereas, 1 equiv. of CO2 is captured by 1 equiv. of dianion during the electrochemical reduction of DCNQ and CNQ. Furthermore, CO2 adducts should be the carbonate type products according to the theoretical calculation results by Gaussian 09 package.

We also recommend Trading Suppliers and Manufacturers of 2,3-Dichloro-1,4-naphthoquinone (cas 117-80-6). Pls Click Website Link as below: cas 117-80-6 suppliers

Prev:Interaction of 2,3-Dichloro-1,4-naphthoquinone (cas 117-80-6) with n-butylamine in halocarbon solvents
Next:Original ArticleCharge–transfer reaction of 2,3-Dichloro-1,4-naphthoquinone (cas 117-80-6) with crizotinib: Spectrophotometric study, computational molecular modeling and use in development of microwell assay for crizotinib)